The Janssen Biotech, Inc/Johnson & Johnson COVID-19 vaccine received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) on February 27, joining the Pfizer-BioNTech and Moderna vaccines that received EUA in December 2020.
The healthcare sector has begun grappling with a repeat challenge…
In today’s digital age, social media channels such as Facebook,…
The COVID-19 pandemic has amplified existing personnel shortages in hospitals and…